Concept
Extramedullary hematopoiesis
Publications associées (48)
New approaches to uncover the minimally functional hematopoietic niche using the adipocytic differentiation axis: pharmacological modulation and adrenal niche induction
Hematopoietic Stem and Progenitor Cells (HSPCs) reside in their niche, a structure that regulates the balance of cellular quiescence, self-renewal and commitment towards differentiated cells. This highly plastic niche is formed by several cellular players, ...
EPFL2022Niche-Mediated Integrin Signaling Supports Steady-State Hematopoiesis in the Spleen
Outside-in integrin signaling regulates cell fate decisions in a variety of cell types, including hematopoietic stem cells (HSCs). Our earlier published studies showed that interruption of periostin (POSTN) and integrin-av (ITGAV) interaction induces faste ...
AMER ASSOC IMMUNOLOGISTS2021Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia
Filipe Amândio Brandão Sanches Vong Martins
Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases, with a variable probability of transformation into acute leukemia, which is, in the vast majority of cases, of myeloid lineage. Nevertheless, rare cases of acute lymphoblastic leukemia ...
SPRINGER2020Blood Flow to the Spleen is Altered in a Mouse Model of Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is a neuromuscular disorder affecting young children. While pre-clinical models of SMA show small spleens, the same is not true in humans. Here, we show by doppler ultrasonography decreased splenic blood flow in Smn(2B/-) mice ...
2020Modeling hematopoietic stem cell dynamics in bioengineered niches
Bone marrow transplantation is a well-established medical procedure for the treatment of various hematologic diseases. However, the relatively low number of hematopoietic stem cells (HSCs) that can be harvested, especially from umbilical cord blood, limits ...
EPFL2019Metabolic and microenvironmental strategies to accelerate hematopoietic recovery post-aplasia
Vasco Ledebur de Antas de Campos
The procedure-associated mortality rate of bone marrow transplantations (BMT) remains close to 25%. The BMT is therefore only indicated for life-threatening diseases, with no replacement of this technology to be expected in the foreseeable future. Modest i ...
EPFL2019